Pfizer : PFE

All Pfizer Articles

1490 Articles

Paul Ausick | Oct 30, 2015 at 4:01 PM EDT

The 4 Stocks That Sank the Dow on Friday

October 30, 2015: Markets opened higher on Friday before falling into the red until the early afternoon. Financial stocks could…

Paul Ausick | Oct 29, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the DJIA Thursday

ThinkstockOctober 29, 2015: Markets opened lower on Thursday after a GDP report that was a bit softer than expected and…

Jon C. Ogg | Oct 29, 2015 at 11:05 AM EDT

What a Combined Allergan and Pfizer Might Actually Look Like

Allergan has issued a press release that confirms some of the rumors floating in the market that it has been…

Jon C. Ogg | Oct 27, 2015 at 10:05 AM EDT

How Pfizer Stacks Up Against Merck on Earnings

Pfizer and Merck both released their third-quarter earnings on Tuesday morning. So, which drug giant is looking better after earnings?

Chris Lange | Oct 27, 2015 at 9:05 AM EDT

Short Sellers Have Mixed Views on Major Pharma

The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Oct 26, 2015 at 3:25 PM EDT

What to Look For in Pfizer’s Earnings

Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.

Lee Jackson | Oct 26, 2015 at 10:15 AM EDT

4 Merrill Lynch Top-Yielding Dividend Stocks to Buy for Q4

Most investors have had a rough 2015, and with the Nasdaq the only index that is up for the year…

Chris Lange | Oct 25, 2015 at 9:10 AM EDT

5 Dow Stocks Reporting Earnings This Week

24/7 Wall St. has put together a preview of Apple, Exxon and some of the major Dow Jones Industrial Average…

Lee Jackson | Oct 23, 2015 at 8:35 AM EDT

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

24/7 Wall St. screened the Merrill Lynch research universe for pharmaceutical stocks paying solid dividends that are rated Buy, and…

Paul Ausick | Oct 21, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the DJIA Wednesday

ThinkstockOctober 21, 2015: Markets opened higher on Wednesday on the trail of gains in both Japan and Europe. Shanghai closed…

Paul Ausick | Oct 20, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the Dow Tuesday

ThinkstockOctober 20, 2015: Markets opened lower on again on Tuesday as investors trailed along after mixed Asian and European equities…

Jon C. Ogg | Oct 20, 2015 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Bluebird Bio, Boston Beer, Etsy, Gilead, Pfizer, PMC-Sierra, Valeant and More

Tuesday's top analyst upgrades, downgrades and initiations include Bluebird Bio, Boston Beer, Etsy, Gilead Sciences, Pfizer, PMC-Sierra and Valeant Pharmaceuticals.

Paul Ausick | Oct 15, 2015 at 4:01 PM EDT

The 4 Stocks That Dominated the Dow on Thursday

ThinkstockOctober 15, 2015: Markets opened higher on Thursday following a strong showing for stocks in both Asia and Europe. Biotech…

Lee Jackson | Oct 14, 2015 at 8:25 AM EDT

5 Dividend-Paying Blue Chip Stocks Trading Under 15 Times Forward Earnings

The bottom line is volatility at higher levels may be here to stay for some time. Owning low-multiple, dividend-paying blue…

Lee Jackson | Oct 12, 2015 at 10:15 AM EDT

Jefferies Franchise Pick Stocks to Buy That Also Pay Big Dividends

These Jefferies Franchise picks with solid dividends are perfect for long-term accounts that like to employ a buy-and-hold strategy.

1 … 56 57 58 59 60 … 100

Pfizer : PFE

All Pfizer Articles

The 4 Stocks That Sank the Dow on Friday

The 4 Stocks That Weighed on the DJIA Thursday

What a Combined Allergan and Pfizer Might Actually Look Like

How Pfizer Stacks Up Against Merck on Earnings

Short Sellers Have Mixed Views on Major Pharma

What to Look For in Pfizer’s Earnings

4 Merrill Lynch Top-Yielding Dividend Stocks to Buy for Q4

5 Dow Stocks Reporting Earnings This Week

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

The 4 Stocks That Weighed on the DJIA Wednesday

The 4 Stocks That Weighed on the Dow Tuesday

Top Analyst Upgrades and Downgrades: Bluebird Bio, Boston Beer, Etsy, Gilead, Pfizer, PMC-Sierra, Valeant and More

The 4 Stocks That Dominated the Dow on Thursday

5 Dividend-Paying Blue Chip Stocks Trading Under 15 Times Forward Earnings

Jefferies Franchise Pick Stocks to Buy That Also Pay Big Dividends

SETM Is Up 27% YTD and 150% Over a Year. The S&P 500? Not Even Close.

A 61-Year-Old Widow Claimed Survivor Benefits While Still Working, Then the Earnings Test Triggered a $1-for-$2 Clawback

A Covered Call ETF That Pays 6% Is Beating Vanguard’s Biggest International ETF Right Now

A 61-Year-Old Widow Claimed Survivor Benefits While Still Working, Then the Earnings Test Triggered a $1-for-$2 Clawback

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

SETM Is Up 27% YTD and 150% Over a Year. The S&P 500? Not Even Close.

A 61-Year-Old Widow Claimed Survivor Benefits While Still Working, Then the Earnings Test Triggered a $1-for-$2 Clawback

Pfizer : PFE

All Pfizer Articles

The 4 Stocks That Sank the Dow on Friday

The 4 Stocks That Weighed on the DJIA Thursday

What a Combined Allergan and Pfizer Might Actually Look Like

How Pfizer Stacks Up Against Merck on Earnings

Short Sellers Have Mixed Views on Major Pharma

What to Look For in Pfizer’s Earnings

4 Merrill Lynch Top-Yielding Dividend Stocks to Buy for Q4

5 Dow Stocks Reporting Earnings This Week

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

The 4 Stocks That Weighed on the DJIA Wednesday

The 4 Stocks That Weighed on the Dow Tuesday

Top Analyst Upgrades and Downgrades: Bluebird Bio, Boston Beer, Etsy, Gilead, Pfizer, PMC-Sierra, Valeant and More

The 4 Stocks That Dominated the Dow on Thursday

5 Dividend-Paying Blue Chip Stocks Trading Under 15 Times Forward Earnings

Jefferies Franchise Pick Stocks to Buy That Also Pay Big Dividends

SETM Is Up 27% YTD and 150% Over a Year. The S&P 500? Not Even Close.

A 61-Year-Old Widow Claimed Survivor Benefits While Still Working, Then the Earnings Test Triggered a $1-for-$2 Clawback

A Covered Call ETF That Pays 6% Is Beating Vanguard’s Biggest International ETF Right Now

Featured Reads

A 61-Year-Old Widow Claimed Survivor Benefits While Still Working, Then the Earnings Test Triggered a $1-for-$2 Clawback

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself